Thomas Swinnen

Global Healthcare Executive | President Fresenius Medical Care | COO | MedTech | Operating advisor & Board member

Belgium

About

Senior healthcare executive driving value creation in complex, global MedTech and Pharma businesses. Proven track record leading large P&Ls, integrating major acquisitions, and guiding organizations through transformation, market expansion, and strategic change. As Executive Vice President, International Commercial Operations, Care Enablement at Fresenius Medical Care, I lead a global commercial organization across five regions, with a mandate to strengthen commercial execution, improve margin and pricing discipline, and accelerate customer and patient impact at scale. I am passionate about healthcare worldwide — shaping market access, driving innovation, and ensuring patients benefit from life-saving therapies.

Experience

  • President, International Care Enablement — Fresenius Medical Care at Fresenius Medical Care
    Jan 2025 - Present · 1 yr 11 mos

  • Strategic Advisor at Advent International
    Sep 2024 - Sep 2025 · 1 yr 1 mo

    Strategic Thinking, Go-to-Market Strategy and +3 skills

  • Chief Customer Officer, Johnson & Johnson MedTech, U.S at Johnson & Johnson MedTech
    Jul 2022 - Oct 2024 · 2 yrs 4 mos

    Charged with developing and implementing the J&J MedTech end-to-end Commercial Excellence strategy, including direct management of the US Key Accounts, Customer operations, Global pricing and Competitive analytics ▪ Implemented an end-to-end J&J MedTech Commercial Excellence strategy, through innovative data strategies and strengthening commercial execution, improving ROI and cashflow. ▪ Increased customer collaboration and improving access for the J&J Med Tech businesses. − Strengthened key stakeholders ‘relationships (IDNs, GPOs, Gov’t accounts) while creating improved access and establishing strategic partnerships. − Advanced portfolio offerings, implemented innovative contracting strategies and accelerated data science capabilities to improve decision making. ▪ Through global competitive insights and strengthening pricing strategy execution, overall J&J MedTech delivered, for the first time in +8 years, price gains.

  • Johnson & Johnson Vision (11 yrs 11 mos)
    • President, North America
      Feb 2019 - Jul 2022 · 3 yrs 6 mos

      Responsible for the overall strategy, operations and financial performance of J&J Vision North America. This includes delivering on commercial strategies and managing cross-functional teams while managing P&L accountability. ▪ Transformed the Consumer and Customer experience through innovative digital and channel strategies, delivering within 6 months 3.5pt share growth with partner accounts. ▪ Refocus of product portfolio strategy, incl NPI, recapturing market leadership in premium category ▪ Achieving highest NA overall share since ’17 and highest professional and brand equity score since ’15

    • Global Vice President, Eye Health Integration
      Mar 2018 - Apr 2019 · 1 yr 2 mos

      Board member J&J Vision, responsible for the integration of acquisitions into the existing business structure with focus on aligning processes, cultures, and strategies to ensure the intended business synergies. ▪ Successful integration of the Abbott Medical Optics into J&J Vision while delivering on the acquisition model. ▪ Acquisition and integration of TearScience, Sightbox.

    • VP and Managing Director, Vision Western Europe
      Apr 2015 - Apr 2018 · 3 yrs 1 mo

      Managing the J&J Vision Developed Markets (Western Europe) business, as well as leading the EMA Category and Key Account teams and having full P&L accountability. ▪ Shifted organizational focus to acceleration of new product category (presbyopia), driven by customer and market insights and analytics. Resulted in additional +3% growth within 1 year. ▪ Transforming team culture with emphasis on empowerment and competitiveness. Led to market beating performance in ’16 & ’17, with growth 2.5 times category and becoming market leader in ’17. • Turnaround of the UK market, refocusing on key customer and consumer insights and implementing a new go-to-market strategy. Led to accelerated sales growth and returning to share gain for the first time in 3 years.

    • Managing Director, Vision Latin America
      Jan 2013 - Apr 2015 · 2 yrs 4 mos

      Leading the business strategies and operations across Latin America for J&J Vision, as well as market development and expansion. Included managing the full regional P&L, building key account partnerships and setting go-to-market strategies. ▪ Accelerated launch of new products while implementing business model innovation in Brazil. Resulted in +10pts of share gain within one year. ▪ Project lead for the global Vision transformation project with aim to accelerate targeted growth opportunities, establish country investment prioritization and develop global marketing and analytics capabilities.

    • CFO | Chief Finance Officer | J&J Vision EMEA & Latin America
      Sep 2010 - Dec 2012 · 2 yrs 4 mos

      Overseeing the financial strategy for J&J Vision Europe. Responsible for managing budgeting, forecasting, financial reporting, and driving profitability while supporting business growth in the region. ▪ Acquired Russian company, lead due diligence and negotiations. Accelerated growth in Russia to 30% within year. ▪ Implemented EMA investment model/pricing strategy, enabling +10% year on year growth.

  • The Janssen Pharmaceutical Companies of Johnson & Johnson (9 yrs 4 mos)
    • Commercial Director & CFO | J&J Pharma | Janssen | Russia & CIS
      May 2008 - Sep 2010 · 2 yrs 5 mos

      • Commercial Director, responsible for procurement, IT and price & contract negotiations with key accounts, government & distributors • As CFO, full P&L responsibility, developing budgets, preparing & evaluating investment plans, all financial & procurement activities • Redesigned & implemented new operating model achieving significant growth in Russia & CIS, while reducing cash flow risk • Exited main distributor with no market disruption or customer impact

    • Finance Director R&D | Global ChemPharm Development, Discovery EMEA
      May 2006 - May 2008 · 2 yrs 1 mo

      Finance Director R&D | Global ChemPharm Development, Discovery EMEA | China & Global Pre-Clinical Research | Controller for Global R&D Spend • Responsible for global finance team supporting J&J Pharmaceutical research & for the consolidation & analytics of global R&D spend outside of the USA • Supported global redesign of all R&D discovery units which led to refocus of capabilities of each discovery unit (eg oncology & pain) and the creation of centres of excellence • Established unique discovery and pre-clinical research unit in China to develop market specific medicines. Played financial lead in negotiations with the Chinese government • Managed a team in the US and Belgium

    • Finance Director Supply Chain & Operations, Italy | J&J Pharma Janssen
      May 2004 - May 2006 · 2 yrs 1 mo

      • Finance director of the Medical Devices plant (Cordis) and the Pharmaceutical production facility (Janssen) • Established lean strategy (Visual Factory) which, after external audit, was recognized to be the leanest plant in J&J EMEA • This, in turn, led to two workshops held with McKinsey & external plants and, subsequently, all pharmaceutical plants were part of a global restructuring • Additionally, responsible for IT, Process Excellence and Procurement

    • Worldwide Controller, J&J Chemical Production | J&J Pharma Janssen
      Jun 2001 - Jun 2004 · 3 yrs 1 mo

      Worldwide Controller J&J Chemical Production | Member of Global Chemical - Board | Financial Controller of all chemical plants within J&J Pharma (USA, Belgium, Ireland, Australia): • Finance lead in successful request to build pilot plant in Belgium • Established new performance management system across all chemical plants